Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Wisner

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
The American Journal of Psychiatry|December 1, 2000
Risk-benefit decision making for treatment of depression during pregnancyK L Wisner, D A Zarin, E S Holmboe, et al.
Clinical Pharmacology and Therapeutics|April 3, 2016
Rationale and design for an investigation to optimize selective serotonin reuptake inhibitor treatment for pregnant women with depressionM J Avram, C S Stika, L J Rasmussen-Torvik, et al.
Translational Psychiatry|January 22, 2021
Pilot validation of blood-based biomarkers during pregnancy and postpartum in women with prior or current depressionE E Redei, J D Ciolino, S L Wert, et al.
Psychopharmacology|August 29, 2012
Pharmacologic evidence to support clinical decision making for peripartum methadone treatmentD L Bogen, J M Perel, J C Helsel, et al.
Psychological Medicine|November 22, 2016
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression ScaleA Di Florio, K Putnam, M Altemus, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
The American Journal of Psychiatry|December 1, 2000
Risk-benefit decision making for treatment of depression during pregnancyK L Wisner, D A Zarin, E S Holmboe, et al.
Clinical Pharmacology and Therapeutics|April 3, 2016
Rationale and design for an investigation to optimize selective serotonin reuptake inhibitor treatment for pregnant women with depressionM J Avram, C S Stika, L J Rasmussen-Torvik, et al.
Translational Psychiatry|January 22, 2021
Pilot validation of blood-based biomarkers during pregnancy and postpartum in women with prior or current depressionE E Redei, J D Ciolino, S L Wert, et al.
Psychopharmacology|August 29, 2012
Pharmacologic evidence to support clinical decision making for peripartum methadone treatmentD L Bogen, J M Perel, J C Helsel, et al.
Psychological Medicine|November 22, 2016
The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression ScaleA Di Florio, K Putnam, M Altemus, et al.
Pageof 4